相关实验视频
Updated: May 12, 2026

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
优化急性缺血性中风的结果:在机械血栓切除术之前, Tenecteplase 的作用
Arsh Haj Mohamad Ebrahim Ketabforoush1, Ali Hosseinpour2, Mohamad Amin Habibi3
1Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Clinical therapeutics
|September 12, 2024
概括
机械血栓切除术 (MT) 之前的 Tenecteplase (TNK) 显示了急性缺血性中风 (AIS) 的改善结果. 这种血栓溶解剂为接受MT的LVO患者提供了一个有前途的替代品.
科学领域:
- 神经科学是一个神经科学.
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性缺血性中风 (AIS) 需要快速再输血来保护大脑组织.
- 血栓缓解药物,如基酶 (TNK) 和机械血栓切除术 (MT) 是关键的治疗方法.
- 阿尔特普拉斯一直是标准,但新的选择正在出现.
研究的目的:
- 评估在急性缺血性中风 (AIS) 机械血栓切除术 (MT) 之前给药的基酶 (TNK) 的疗效和安全性.
- 为了比较TNK与alteplase作为MT前的桥梁疗法.
- 评估TNK在AIS管理中作为阿尔特普拉斯的替代品的潜力.
主要方法:
- 在PubMed,Scopus和Web of Science的系统文献搜索.
- 包括随机对照试验,临床试验和元分析.
- 专注于在2024年之前对人类患者的MT前TNK的研究.
主要成果:
- 与alteplase相比, Tenecteplase (TNK) 显示出更高的纤维素特异性和更长的半衰期.
- 临床试验表明,在MT之前的TNK会导致增强的再通道化,更好的功能结果和更好的安全性.
- 最佳TNK剂量建议在0.25mg/kg;先进的神经成像辅助患者选择.
结论:
- 甲 (TNK) 是一种有前途的AIS桥梁疗法,在机械血栓切除术 (MT) 之前给予时,提供显著的疗效和安全优势.
- 甲酸呈现出一种可行的替代阿尔特酶,有可能改变AIS治疗,特别是在大血管封闭 (LVOs) 方面.
- 需要进一步的大规模RCT和成本效益分析,以巩固TNK在AIS管理中的作用.
相关概念视频
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...

